陈柏谦 李瑛



【摘要】 目的:探討分析大柴胡汤联合柳氮磺胺吡啶肠溶片治疗溃疡性结肠炎的效果。方法:将2018年1-12月本院收治的86例溃疡性结肠炎患者随机分为观察组和对照组,观察组给予大柴胡汤联合柳氮磺胺吡啶肠溶片治疗,对照组仅给予柳氮磺胺吡啶肠溶片治疗,比较两组临床疗效、治疗前后症状评分、黏膜评分、炎性因子水平及不良反应发生情况。结果:观察组总有效率为95.35%,较对照组的79.07%显著提高(P<0.05)。两组治疗前腹泻、腹痛、脓血便及里急后重症状评分比较,差异均无统计学意义(P>0.05);两组治疗后各症状评分均显著下降,且观察组各症状评分下降更显著(P<0.05)。两组治疗前黏膜评分比较,差异无统计学意义(P>0.05);两组治疗后黏膜评分均显著性下降,且观察组黏膜评分下降更显著(P<0.05)。两组治疗前IL-1β、IL-6、TNF-α水平比较,差异均无统计学意义(P>0.05);两组治疗后各指标水平均显著下降,且观察组各指标水平下降更显著(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:大柴胡汤联合柳氮磺胺吡啶肠溶片治疗溃疡性结肠炎可提高临床疗效,改善患者的临床症状,促进结肠黏膜恢复,提高患者生活质量。
【关键词】 大柴胡汤 柳氮磺胺吡啶肠溶片 溃疡性结肠炎
Effect of Dachaihu Decoction Combined with Sulfasalazine Enteric-coated Tablets in the Treatment of Ulcerative Colitis/CHEN Boqian, LI Ying. //Medical Innovation of China, 2020, 17(15): 0-069
[Abstract] Objective: To explore the effect of Dachaihu Decoction combined with Sulfasalazine Enteric-coated Tablets in the treatment of patients with ulcerative colitis. Method: A total of 86 patients with ulcerative colitis who treated in our hospital from January to December 2018 were randomly divided into the observation group and the control group. The patients in the observation group were treated with Dachaihu decoction combined with Sulfasalazine Enteric-coated Tablets, the control group was treated only with Sulfasalazine Enteric-coated Tablets. The clinical efficacy, symptom score, mucosal score, level of inflammatory factors and occurrence of adverse reactions of two groups were compared. Result: The total effective rate in the observation group was 95.35%, which was significantly higher than 79.07% of the control group (P<0.05). The scores of diarrhea, abdominal pain, bloody purulent stool and tenesmus of two groups were compared, there were no significant differences (P>0.05). After treatment, the scores of symptoms of two groups decreased significantly, and the observation group decreased more significantly (P<0.05). The mucosal scores of two groups before treatment compared, there was no significant difference (P>0.05). The mucosal scores of two groups decreased significantly after treatment, and the observation group decreased more significantly (P<0.05). There were no significant differences in the levels of IL-1β, IL-6, and TNF-α of two groups (P>0.05). The levels of indexes of two groups decreased significantly after treatment, and the observation group decreased more significantly (P<0.05). The incidence of adverse reactions of two groups compared, there was no significant difference (P>0.05). Conclusion: Dachaihu Decoction combined with Sulfasalazine Enteric-coated Tablets in the treatment of ulcerative colitis can improve the clinical efficacy, improve the clinical symptoms of patients, promote the recovery of colonic mucosa and improve the quality of life of patients.
我国传统医学认为溃疡性结肠炎属于“腹泻、痢疾”的范畴,其病因主要为毒邪侵入,最为常见的是湿热,湿热大肠郁蒸,气滞血瘀,脏腑不畅,互为孳生,血脉不畅损伤,生为脓血,但下痢红而白,病为湿邪,性重浊,清除黏腻难,脾阳困阻,伤脾失运,湿热内蕴伺机而侵入,病情反复,难以治愈[14-15]。《类证治裁·痢疾》解释:湿热郁蒸、气血凝滞致溃疡性结肠炎,治疗当以清热,活血为主要原则[16]。本研究结果显示:观察组总有效率达95.35%,腹泻、腹痛、脓血便、里急后重症状评分均显著下降,黏膜评分显著下降,差异均有统计学意义(P<0.05)。说明大柴胡汤联合柳氮磺胺吡啶肠溶片治疗溃疡性结肠炎可提高临床疗效,改善患者的临床症状,促进结肠黏膜的恢复,这主要是由于大柴胡汤主要由柴胡、白芍、黄芩、半夏、枳实、酒大黄、生姜组成,其中柴胡具有疏肝解郁,调节气血之效,白芍补血养肝,止痛收汗之效,黄芩清热解毒,燥湿凉血之效,半夏散结消肿,化痰燥湿,止呕之效,枳实疏肝理气,消痞散结,酒大黄清热解毒,生姜调节脾胃,止呕健脾之效,全方共凑清热解毒、活血降逆,疏肝解郁,理气止痛和胃之效[17-18]。研究显示:溃疡性结肠炎发病与机体内的炎性因子水平密切相关[19-20]。本研究结果显示:观察组IL-1β、IL-6、TNF-α指标水平均显著下降(P<0.05)。说明大柴胡汤联合柳氮磺胺吡啶肠溶片治疗溃疡性结肠炎可降低患者机体内炎性因子水平,保护胃黏膜,也说明大柴胡汤可调节肠道菌群,平衡抗炎和促炎因子的平衡。
综上所述,柴胡汤联合柳氮磺胺吡啶肠溶片治疗溃疡性结肠炎可提高临床疗效,改善患者的临床症状,促进结肠黏膜的恢复,提高患者生活质量。……